Rosacea is a chronic inflammatory medical condition, not a skin type or a skincare failure. It runs on two mechanisms at once: a neurovascular arm, where TRP channels on sensory nerves respond to heat, UV and capsaicin by triggering flushing, and an immune arm, where elevated kallikrein-5 abnormally cleaves cathelicidin into LL-37, driving inflammation and blood-vessel growth.
Effective prescription treatments exist and target the second arm directly. Skincare does not treat rosacea — it reduces the irritant load so that treatment is tolerable.
If this describes your skin, the highest-value action is seeing a dermatologist, not changing your moisturiser.
This article is educational only. Rosacea is a medical condition requiring diagnosis and management by a qualified dermatologist. Nothing here diagnoses, treats or manages rosacea, and no product is recommended for it. Last reviewed August 2026.
- Rosacea is a chronic inflammatory disease, not a cosmetic skin type. It requires medical diagnosis.
- Kallikrein-5 (KLK5) is elevated in lesional rosacea skin, abnormally cleaving the cathelicidin precursor into LL-37 and its fragments.2,3
- LL-37 drives leukocyte chemotaxis, angiogenesis, vasodilation and matrix metalloproteinase activation — which map directly onto the erythema, telangiectasia and papules seen clinically.1,3
- Injecting these peptides into mouse skin reproduced rosacea-like inflammation, which is why cathelicidin is considered causal rather than incidental.4
- TRP channels — TRPV1, TRPA1 and others — are the trigger mechanism. Heat, UV and capsaicin activate them on sensory nerves, producing neurogenic vasodilation.5 This is why spicy food causes flushing.
- Tetracyclines work in rosacea by downregulating KLK5 and cathelicidin, not by killing bacteria — which is why sub-antimicrobial doses are effective.1
- Rosacea is under-recognised in skin of colour, where erythema is harder to see against deeper pigmentation and the condition is frequently mistaken for acne.1
- Skincare's role is reducing irritant load so prescribed treatment is tolerable. It is adjunct, not therapy.
Most articles about rosacea are really articles about skincare routines, with the disease treated as background. That ordering is backwards, and it leads people to spend months adjusting moisturisers for a condition that has effective prescription treatment.
This article does it the other way round: what rosacea actually is, why its triggers work at a mechanistic level, what is prescribed and why that works — and then, last and smallest, what skincare genuinely contributes.
DefinitionWHAT IS ROSACEA?
Rosacea is a chronic inflammatory skin disease characterised by facial erythema, flushing, telangiectasia (visible dilated vessels), and in some presentations papules and pustules, typically affecting the central face.6 It is a diagnosis, made by a clinician, not a description of a skin type.
That distinction is not pedantry. "Sensitive, redness-prone skin" is a cosmetic category you can approach with gentler products. Rosacea is a disease with an identified inflammatory pathway and licensed treatments that act on it. Treating the second as though it were the first is how people lose years.
Persistent central-face redness, easy flushing, visible vessels, or recurring papules that are not typical acne — see a dermatologist. Not because something is seriously wrong, but because rosacea is treatable and self-managing it with skincare is the slow route to a result you can get faster.
THE TWO ARMS OF ROSACEA
Rosacea is often described vaguely as "sensitive blood vessels plus inflammation." The research is considerably more specific, and the specificity is useful — because the two arms are triggered differently and treated differently.
Cathelicidin could have been a bystander — elevated because of inflammation rather than causing it. Researchers tested this by injecting cathelicidin peptides, and the enzymes that produce them, into mouse skin. The result was skin inflammation resembling the pathological changes of rosacea.4
That is why this pathway is treated as central rather than incidental, and why treatments that reduce KLK5 activity make clinical sense.
The practical consequence of the two-arm model: avoiding hot showers and spicy food addresses arm one. It does nothing to arm two. Someone who has meticulously eliminated every trigger and still has persistent redness and papules has not failed at trigger management — they have an untreated inflammatory process.
TriggersWHY DO THE TRIGGERS WORK?
The standard trigger list — heat, sun, spicy food, alcohol, stress, cold wind — is accurate but usually presented without explanation, which makes it feel arbitrary. It is not.
| Trigger | Mechanism | Which arm |
|---|---|---|
| Heat — showers, sun, hot drinks | Direct TRPV1 activation on sensory nerves5 | Neurovascular |
| Capsaicin — chilli, spicy food | TRPV1 is the capsaicin receptor. This is a literal molecular match, not an analogy5 | Neurovascular |
| UV radiation | Activates TRP channels and upregulates cathelicidin expression5,8 | Both |
| Cold, wind | TRPA1 activation; barrier disruption | Neurovascular |
| Alcohol | Systemic vasodilation | Neurovascular |
| Harsh products, fragrance | Barrier disruption increases irritant access | Aggravates both |
UV. It activates TRP channels directly and upregulates cathelicidin expression.5,8 Every other trigger on that list is optional or occasional; sun exposure is daily. If you do one thing from this article, daily broad-spectrum sun protection is the one with the most mechanism behind it.
Trigger identification is genuinely individual — people differ substantially in which stimuli produce a response. Keeping a simple record of what preceded a flare is more useful than adopting someone else's avoidance list wholesale.
Under-recognisedROSACEA IN SKIN OF COLOUR
This is the part of the rosacea conversation most articles omit entirely, and it matters more in India than almost anywhere.
Rosacea is widely regarded as a condition of fair, northern European skin. It is not — it occurs across skin tones, but it is substantially under-recognised in skin of colour.1
The reason is largely optical. Erythema — the defining sign — is far harder to see against deeper background pigmentation. The clinical presentation shifts accordingly: less obvious redness, and more warmth, burning, stinging, swelling and papules. Those features are readily mistaken for acne, and the diagnosis is frequently delayed or missed.
Three consequences follow, and they are practical:
- If you have been treated for acne that never quite behaved like acne — burning rather than soreness, flushing with heat, papules without comedones — that is worth raising specifically with a dermatologist.
- Standard acne treatment can make rosacea worse. Benzoyl peroxide and exfoliating acids are irritants, and irritation feeds the inflammatory arm.
- Post-inflammatory hyperpigmentation compounds it. On deeper skin tones, the inflammation leaves marks that persist after the flare settles, adding a second complaint on top of the first.
Comprehensive review of rosacea in skin of colour has been published in the Indian dermatological literature,1 and it is worth a dermatologist's attention rather than a self-diagnosis.
Medical managementWHAT DERMATOLOGISTS PRESCRIBE, AND WHY
Naming these is education, not recommendation — but knowing that effective options exist is the single most useful thing this article can tell you, because the alternative is years of moisturiser experiments.
Tetracyclines are the only systemic therapy with FDA approval for rosacea, with doxycycline generally preferred.1 The interesting part is why they work.
They act by downregulating kallikrein-5 and cathelicidin, reducing neutrophil chemotaxis, reactive oxygen species generation and nitric-oxide-mediated vasodilation.1 This is an anti-inflammatory action, not an antibacterial one — which is why sub-antimicrobial doses are effective, since no bacterium is involved in rosacea's pathogenesis.1
A drug from the antibiotic class, working through a non-antibiotic mechanism, at a dose too low to be antibacterial. That is a good illustration of how far rosacea treatment has moved from "kill the bug."
Topical prescription options in common use include azelaic acid, ivermectin, metronidazole and, for persistent erythema specifically, brimonidine. Light-based treatment is used for telangiectasia. Which of these is appropriate depends on the presentation, and that assessment is a clinician's job.
A great deal of rosacea content says flatly: "avoid all actives." That advice is well-intentioned and, stated that broadly, wrong.
It is sound guidance for irritating cosmetic actives — strong exfoliating acids, high-strength vitamin C, aggressive retinoid use. It is not true of prescribed actives. Azelaic acid is an acid, and it is a first-line topical for rosacea. Ivermectin is a potent active. The distinction is not "active versus gentle"; it is "irritating versus targeted, and who chose it."
WHAT SKINCARE CAN AND CANNOT DO
Here is the honest scope, stated plainly.
Skincare does not treat rosacea. It does not act on kallikrein-5, it does not modulate cathelicidin, and it does not resolve telangiectasia. Any cosmetic product claiming to do those things is making a medicinal claim it cannot support.
What gentle skincare does contribute is reducing the irritant load. Rosacea skin has a compromised barrier, elevated water loss, and heightened reactivity — and a disrupted barrier lets irritants in, which feeds inflammation. Reducing that input is genuinely useful, and it has a second benefit: prescribed topicals for rosacea are frequently irritating themselves, and people who cannot tolerate them stop using them. A calm barrier is often what makes treatment sustainable.
Ingredients commonly used in gentle, barrier-supportive formulation include glycerin and other humectants, ceramides and other barrier lipids, squalane, and niacinamide. These are described here as general ingredient categories — not as a protocol, and not as treatment for a medical condition. A note on niacinamide in particular: it is widely tolerated, but some people experience flushing with it, which on rosacea-prone skin is worth knowing before you start.
AggravatorsWHAT TENDS TO MAKE THINGS WORSE
- Fragrance and essential oils. Common irritants; "natural" is not a tolerability claim.
- Physical scrubs and cleansing brushes. Mechanical barrier disruption.
- Hot water. Direct TRPV1 activation. Lukewarm only.
- Strong cosmetic exfoliating acids and high-strength vitamin C, self-selected. Different from a prescribed azelaic acid.
- Product-stacking and frequent switching. Each new product is an untested variable on reactive skin.
- Skipping sun protection. The trigger with the most mechanism behind it.
FREQUENTLY ASKED QUESTIONS
- Rosacea in skin of color: a comprehensive review. Indian Journal of Dermatology, Venereology and Leprology. 2021.
- Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations. Journal of Clinical and Aesthetic Dermatology.
- Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nature Medicine. 2007;13(8):975–980.
- Rosacea as a disease of cathelicidins and skin innate immunity. Journal of Investigative Dermatology Symposium Proceedings.
- The exposomal imprint on rosacea. Journal of the European Academy of Dermatology and Venereology. 2025. (TRPA1/TRPV1 activation by UV, heat and spicy foods.)
- Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology. Archives of Dermatological Research / rosacea pathogenesis literature.
- Rosacea pathogenesis and therapeutics: current treatments and a look at future targets. (TRPV gene expression and immunolabelling in rosacea biopsies.)
- Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.
© 2026 Boldpurity · For educational purposes only · Not to be reproduced without permission.
